GATE2BRAIN WINNER OF THE BARCELONA ACTIVA PRE-ACCELERATION COMPETITION

GATE2BRAIN winner of the Barcelona Activa Pre-acceleration competitionBarcelona Activa

Gate2Brain winner of the Barcelona Activa Pre-acceleration Competition

Barcelona Activa has accompanied Gate2Brain together with 9 other companies Eyme, MigaLabs, Myosleeve, Aptugo, Reveal Genomics, Electrical Systems Analysis Methods, REMTech, MV-Optimizer in the 7th edition of its pre-acceleration program. It is a program that supports entrepreneurial projects in their initial stages with a high technological impact.

Through the Pre-Acceleration Program, the selected teams have had the opportunity to validate their business model from excellent experts and to share experiences with a dynamic entrepreneurial community.

On Demo day, that was held on July 7th, Gate2Brain  along with the other selected companies presented its project to a panel of experts. Gate2Brain was the company awarded. Our CEO, Meritxell Teixidó, received  the prize that consisted of 5,000 € and an acceleration process to the MediaTIC incubator, where Gate2Brain will be part of the community of companies that are already hosted in the Barcelona Activa network of incubators.

With the Pre-acceleration program, Barcelona Activa has once again committed to science, helping to position Barcelona as a technological hub of reference in southern Europe and as a capital of innovation and digital talent.

/by
You might also like
Foment shows how the leadership of a new generation of female innovators is already a reality at # MWC21Foment del Treball Foment shows how the leadership of a new generation of female innovators is already a reality at # MWC21
‘Tractor’ proteins that carry drugs to the brain as therapy for incurable pediatric cancer
¿Cómo transportar fármacos al cerebro para tratar patologías?La Vanguardia How to transport drugs to the brain to treat pathologies?
Within the framework of the discussion-based interview series, Exploration Science, in which scientists talk about their ventures and areas of expertise, our CEO, Dr. Meritxell Teixidó, and the first and only APS American Peptide Idol joined @CEM's Dr. Wendy Hartsock to discuss the work @Gate2Brain is doing in pediatric oncology, dive into the technology, and talk about empathetic leadership and the power of diversity.CEM Exploration Science with Dr. Wendy Harsock
Una tecnología para ayudar a tratar el cáncer infantilgate2brain A technology to help treat pediatric cancer
Gate2Brain abre una ronda puenteo de un millón de euros para ensayos preclínicoPlantaDoce Gate2Brain opens one million euro bridge round for preclinical trials
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

Foment shows how the leadership of a new generation of female innovators is... Foment shows how the leadership of a new generation of female innovators is already a reality at # MWC21Foment del Treball Top Spain Medical Startups 2021 Gate2Brain among the 101 top medical startups in Spain